September 2024 was not just any month; it was a remarkable chapter in the field of drug demand reduction. Picture this: from 8th to 13th September 2024, drug use prevention influencers from Africa and Asia converged in Kerala, India for a...
A study funded by the NIH found that adults with opioid use disorder (OUD) who take higher doses of buprenorphine, an opioid addiction treatment medication, have a lower risk of emergency department or inpatient visits related to behavioral...
Objective: Ayahuasca, a plant-based substance from the Amazon, is gaining attention for its potential in treating addiction. However, there is little research on the role of purging (mainly vomiting), which is a key part of the healing...
Open September 4 - October 11, 2024
ASAM members and non-members are invited to submit abstracts for poster presentations, focus sessions, and workshop sessions. ASAM encourages investigators, researchers, clinicians...
Abstract submission now open until November 15, 2024
Useful information: How to submit an abstract in ConfTool
Submission Guidelines:
Importance Prescribing medications for opioid use disorders (MOUD), including buprenorphine, naltrexone, and methadone, to adolescents remains an underused evidence-based strategy for reducing harms associated with opioid use.
O...
Importance Although cases of neonatal opioid withdrawal syndrome (NOWS) increased 5-fold in recent years, no study has examined national hospital readmission rates for these infants.
Objective To examine hospital readmissions...
Importance In 2023, more than 80 000 individuals died from an overdose involving opioids. With almost two-thirds of the US jail population experiencing a substance use disorder, jails present a key opportunity for providing...
Save the date! The 2025 NIDA International Forum will take place as an in-person meeting in New Orleans...
